PNTG The Pennant Group, Inc. Common Stock
XNAS
41.04
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $22.25 – $42.74
- YTD
- +47.47%
- IV Rank (30D)
- 59.96
- Straddle Price
- $5.38
- P/C Vol Ratio
- 0.36
- Market Cap
- $1.4B
- Open
- $41.17
- Day Range
- $40.67 – $41.48
- Volume
- 207,527
- Prev Close
- $41.48
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.67% (VRP-adj) |
| WACC | 10.04% |
| Volatility Risk Premium | +66.0pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 26.9% |
| Rev. Growth (YoY, DCF input) | +30.0% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 9.0% |
| Book / Price | 27.7% |
| Gross Margin (TTM) | 18.5% |
| FCF Margin (TTM) | 3.1% |
| Debt / Equity | 0.48 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +24.6% (reverse-DCF on current price) |
| SMA 50 | $39.53 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $40.38 |
| Bollinger Width / SMA20 | 21.7% (drives anchor stability) |
| Net Debt | $0.2B |
| Market Cap | $1B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $56.73 | 28% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $26.90 | 9% | median 26.9× · 8 peers |
| Peer EV/EBITDA | $33.50 | 9% | median 17.2× · 8 peers |
| Peer P/B | $45.59 | 9% | median 4.0× · 8 peers |
| Peer P/S | $46.50 | 9% | median 1.4× · 8 peers |
| Market Anchor (SMA50) | $39.53 | 23% | stability 41% (BB-width) |
| Options Expected (B-L 30d) | $40.93 | 14% | 10 strikes · skew +0.07 |

- Industry (SIC)
- SERVICES-HEALTH SERVICES (8000) · industry map
- Exchange
- XNAS
- Market Cap
- $1.4B
- Employees
- 9,700
- List Date
- 2019-09-19
- CIK
- 0001766400
- Next Earnings
- 2026-11-04 (After-Close)
- EPS Forecast
- $0.28 (1 est.)
- Headquarters
- Eagle, ID
- Homepage
- https://www.pennantgroup.com
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -12.51% | -30.02% | 20.04% | 5.70% | 0.04% | -0.75% | -2.92% |
| Feb | -5.87% | -1.22% | 13.19% | 21.18% | -14.46% | 19.45% | 5.38% |
| Mar | -12.56% | 24.03% | -5.12% | 7.39% | 11.63% | -9.88% | 2.58% |
| Apr | -12.19% | -14.68% | 0.29% | 3.98% | 0.83% | 3.20% | -3.10% |
| May | -15.36% | 15.03% | -13.85% | 10.72% | 12.94% | 9.42% | 3.15% |
| Jun | 15.54% | -28.95% | 2.33% | 0.06% | 3.54% | 15.47% | 1.33% |
| Jul | -19.39% | 3.57% | -6.89% | 27.39% | -17.95% | 7.13% | -1.02% |
| Aug | -6.71% | 16.42% | 5.64% | 14.54% | 8.79% | -8.51% | 5.03% |
| Sep | -9.47% | -31.96% | -7.56% | 9.88% | 5.26% | 3.34% | -5.08% |
| Oct | -8.81% | 15.05% | -1.54% | -2.89% | -2.64% | 5.80%* | 0.83% |
| Nov | -25.01% | -20.77% | 27.63% | -4.03% | 10.58% | -- | -2.32% |
| Dec | 14.43% | 4.87% | 1.83% | -15.97% | -0.88% | -- | 0.86% |
| Total | -67.06% | -53.11% | 32.62% | 98.95% | 12.93% | 49.29% | 12.27% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Here is the LLM Stock Analysis Report:
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers:
- Technical indicators suggest a strengthening trend, with MACD and ADX signaling a bullish momentum.
- Recent news headlines indicate positive developments for Pennant, which may have contributed to the stock's upward movement.
Primary risks:
- High implied volatility could lead to increased price fluctuations.
- Earnings expectations are uncertain due to lack of recent earnings data.
Investment thesis: Pennant appears poised for continued growth, driven by its acquisition strategy and industry tailwinds. The company's low volatility and stable beta suggest a relatively defensive posture, which may appeal to investors seeking lower-risk opportunities.
Recent news sentiment impact: Positive news headlines have contributed to the stock's upward movement, suggesting that Pennant's recent acquisitions and earnings announcements have positively impacted investor sentiment.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Bullish
- Medium-term (1-3 months): Bullish
- Long-term (3-12 months): Neutral
Support/Resistance Levels:
- SMA 20: $33.03
- SMA 50: $32.91
- Upper Bollinger Band: $36.24
Momentum Signals:
- RSI: 64.26 (neutral)
- MACD signal: Bullish
- Bollinger Bands position: Neutral
Volume Analysis:
- Volume SMA 20: 314278.60
- On-Balance Volume (OBV): 13808833.78
- Volume Rate of Change: 729.20%
News & Sentiment Analysis
Recent Headlines Summary:
- Pennant announces several acquisitions in the senior living community sector, indicating a growth strategy.
Sentiment Assessment: Positive
Catalyst Identification:
- Upcoming earnings release and call (May 4)
- Potential for additional acquisitions or partnerships in the senior living space
Market Narrative: The recent positive news headlines align with the technical signals, suggesting that Pennant's acquisition strategy is driving its upward movement.
Risk & Volatility Assessment
Risk Assessment:
- Beta: 0.48 (low volatility)
- Alpha: 0.20
- Correlation: 0.15
- Stock Volatility: 0.40
Volatility Regime: Low volatility regime
Options Market Signals: IV Rank: 12.5% (low) Put/Call Volume Ratio: 27.00 (bearish sentiment)
Downside Protection:
- Support level: SMA 20 ($33.03)
- Risk management considerations: Use stop-loss levels to manage potential losses.
Market Context & Positioning
Sector Performance: Pennant's sector is experiencing moderate growth, with a correlation coefficient of 0.15.
Institutional Activity: Volume patterns suggest institutional interest in Pennant, with an increased volume flow and open interest in calls and puts.
Correlation Analysis: Pennant's stock price has a low correlation to the market (R-squared: 0.15), indicating that it may be less susceptible to broad market fluctuations.
Relative Valuation: Pennant is positioned within a trading range, with its current price near the upper end of the range.
Key Levels & Action Items
Critical Price Levels:
- Support level: SMA 20 ($33.03)
- Resistance level: Upper Bollinger Band ($36.24)
Breakout/Breakdown Levels:
- Breakout above $36.24 could indicate further upward momentum.
- Breakdown below $33.03 could suggest a return to the mean.
Time-Sensitive Catalysts:
- Earnings release and call on May 4
- Potential additional acquisitions or partnerships in the senior living space
Risk Management:
- Use stop-loss levels to manage potential losses.
- Monitor volume patterns and options activity for signs of increased volatility or institutional interest.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-11-01 | After-Close | 8.48% | 23.28% | 2.75x | Exceeded |
| 2023-05-04 | After-Close | 12.73% | 6.94% | 0.55x | Within |
| 2023-08-08 | After-Close | 22.53% | 2.14% | 0.09x | Within |
| 2023-11-07 | After-Close | 10.97% | 8.05% | 0.73x | Within |
| 2024-02-28 | After-Close | 13.21% | 10.49% | 0.79x | Within |
| 2024-05-06 | After-Close | 14.14% | 3.06% | 0.22x | Within |
| 2024-08-06 | After-Close | 11.54% | 1.85% | 0.16x | Within |
| 2024-11-06 | After-Close | 12.61% | 3.38% | 0.27x | Within |
| 2025-02-27 | Pre-Market | 21.18% | 0.16% | 0.01x | Within |
| 2025-05-06 | After-Close | 17.79% | 3.43% | 0.19x | Within |
| 2025-08-06 | Pre-Market | 16.45% | 0.32% | 0.02x | Within |
| 2025-11-05 | After-Close | 13.91% | 5.64% | 0.41x | Within |
| 2026-02-25 | After-Close | 17.23% | 7.86% | 0.46x | Within |
| 2026-05-06 | After-Close | 14.99% | 9.84% | 0.66x | Within |
| 2026-08-05 | After-Close | 10.76% | 0.64% | 0.06x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
PNTG Options Activity & IV Rank
PNTG IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 34th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
PNTG Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $3.69K | 100.00% | 2026-06-30 |
PNTG Insider Trading (Form 4)
Latest: 2026-10-19| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Stephen M R Covey | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-10-19 | Barry M Smith | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-10-19 | Scott E Lamb | Director | Award (A) | +2,400 | — | EDGAR | |
| 2026-10-19 | John G. Nackel | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-10-19 | Christopher R. Christensen | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-10-19 | Gregory K Morris Sr. | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-10-19 | Suzanne D. Snapper | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-08-10 | Kirk Sterling Cheney | EVP, GC and Corp Secy | Sell (S) | −1,393 | $38.52 | -$53.7K | EDGAR |
| 2026-08-10 | Brent Guerisoli | Chief Executive Officer | Sell (S) | −4,285 | $38.52 | -$165.1K | EDGAR |
| 2026-08-10 | Jason Paul Steik | Chief Clinical Officer | Sell (S) | −1,394 | $38.52 | -$53.7K | EDGAR |
| 2026-07-17 | Suzanne D. Snapper | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-07-17 | Stephen M R Covey | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-07-17 | Barry M Smith | Director | Award (A) | +1,900 | — | EDGAR | |
| 2026-07-17 | Scott E Lamb | Director | Award (A) | +2,400 | — | EDGAR | |
| 2026-07-17 | Gregory K Morris Sr. | Director | Award (A) | +1,900 | — | EDGAR |
PNTG Insider Holdings
13 insiders · @ $41.04| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Christopher R. Christensen | Director | 771,238 | $31.65M | -$2.55M | 41 | 2026-10-19 |
| 2 | Suzanne D. Snapper | Director | 232,264 | $9.53M | $0 | 6 | 2026-10-19 |
| 3 | John G. Nackel | Director | 179,165 | $7.35M | $202.6K | 33 | 2026-10-19 |
| 4 | John J Gochnour | Chief Operating Officer | 145,464 | $5.97M | $13.6K | 18 | 2026-04-17 |
| 5 | Barry M Smith | Director | 104,399 | $4.28M | $449.7K | 25 | 2026-10-19 |
| 6 | Brent Guerisoli | Chief Executive Officer | 99,544 | $4.09M | -$748.9K | 16 | 2026-08-10 |
| 7 | Scott E Lamb | Director | 61,335 | $2.52M | $201.1K | 32 | 2026-10-19 |
| 8 | Stephen M R Covey | Director | 45,950 | $1.89M | $0 | 30 | 2026-10-19 |
| 9 | Gregory K Morris Sr. | Director | 39,200 | $1.61M | $0 | 20 | 2026-10-19 |
| 10 | JoAnne Stringfield | Director | 30,275 | $1.24M | -$249.5K | 31 | 2025-05-23 |
PNTG Board & Officers
As of SEC filings through Oct 19, 2026Directors 7
- Scott E Lamb · since Sep 9, 2019
- Christopher R. Christensen · since Oct 1, 2019
- John G. Nackel · since Oct 1, 2019
- Stephen M R Covey · since Oct 1, 2019
- Barry M Smith · since Apr 1, 2021
- Gregory K Morris Sr. · since Jan 1, 2022
- Suzanne D. Snapper · since May 16, 2025
Officers 5
- Brent Guerisoli · Chief Executive Officer · listed since Mar 2025
- Lynette Walbom · Chief Financial Officer · on file since Aug 2023
- John J Gochnour · Chief Operating Officer · since Sep 9, 2019
- Jason Paul Steik · Chief Clinical Officer · since Apr 17, 2025
- Kirk Sterling Cheney · EVP, GC and Corp Secy · since Apr 17, 2025
Changes in the last 10 years (28)
| May 23, 2025 | JoAnne Stringfield reported in an SEC filing no longer being a director |
| May 16, 2025 | Suzanne D. Snapper became a director |
| Apr 17, 2025 | Kirk Sterling Cheney became EVP, GC and Corp Secy |
| Apr 17, 2025 | Jason Paul Steik became Chief Clinical Officer |
| Mar 14, 2025 | Brent Guerisoli listed as Chief Executive Officer (previously President) in SEC filings |
| Aug 24, 2023 | Lynette Walbom first on file as Chief Financial Officer |
| Jun 1, 2023 | Jennifer Freeman reported in an SEC filing no longer being Chief Financial Officer |
| Nov 14, 2022 | The company announced the departure of Derek J Bunker as Chief Investment Officer in an SEC filing |
| Jun 7, 2022 | The company announced the departure of Daniel H Walker as Chief Executive Officer in an SEC filing |
| Jan 1, 2022 | Gregory K Morris Sr. became a director |
| Dec 23, 2021 | The company announced the departure of Roderic W Lewis from the board in an SEC filing |
| Apr 1, 2021 | Barry M Smith became a director |
| Jan 1, 2021 | Brent Guerisoli became President |
| Feb 14, 2020 | Daniel H Walker listed as Chief Executive Officer (previously Chairman, Chief Executive Officer and President) in SEC filings |
| Feb 11, 2020 | Derek J Bunker listed as Chief Investment Officer (previously Chief Investment Officer, Executive Vice President & Secretary) in SEC filings |
| Oct 3, 2019 | Ensign Group, Inc reported in an SEC filing no longer being a 10% owner |
| Oct 1, 2019 | Stephen M R Covey became a director |
| Oct 1, 2019 | Roderic W Lewis became a director |
| Oct 1, 2019 | John G. Nackel became a director |
| Oct 1, 2019 | JoAnne Stringfield became a director |
| Oct 1, 2019 | Christopher R. Christensen became a director |
| Sep 9, 2019 | Scott E Lamb became a director |
| Sep 9, 2019 | John J Gochnour became Chief Operating Officer |
| Sep 9, 2019 | Jennifer Freeman became Chief Financial Officer |
| Sep 9, 2019 | Ensign Group, Inc became a 10% owner |
| Sep 9, 2019 | Derek J Bunker became Chief Investment Officer, Executive Vice President & Secretary |
| Sep 9, 2019 | Daniel H Walker became a director |
| Sep 9, 2019 | Daniel H Walker became Chairman, Chief Executive Officer and President |
- Prev
- 1
Not reported recently (1)
- Daniel H Walker · Last reported as a director in an SEC filing dated Jan 19, 2023
PNTG Proposed Insider Sales (Form 144)
Latest: 2026-08-06What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Cheney Kirk Sterling | Officer | 1,393 | $53.7K | 2026-08-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-06 | Guerisoli Brent | Officer, Director | 4,285 | $165.1K | 2026-08-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-06 | Steik Jason Paul | Officer | 1,394 | $53.7K | 2026-08-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-07-10 | Guerisoli Brent | Officer, Director | 3,159 | $131.3K | 2026-07-10 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-07 | Guerisoli Brent | Officer, Director | 3,165 | $128.2K | 2026-07-07 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-22 | Guerisoli Brent | Officer, Director | 4,508 | $158.1K | 2026-05-22 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-14 | Gochnour John J | Officer | 4,639 | $170.7K | 2026-05-14 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-07-28 | Guerisoli Brent | Officer, Director | 3,995 | $93.2K | 2025-07-28 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-07-28 | Guerisoli Brent | Officer, Director | 3,995 | $93.2K | 2025-07-28 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-05-20 | Stringfield JoAnne | Director | 11,954 | $351.8K | 2025-05-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $40.9M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.05% | $35.7M | $75.1B | 2026-10-20 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.02% | $15.3M | — | 2026-09-30 |
| 4 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.10% | $13.0M | $13.6B | 2026-10-20 |
| 5 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.03% | $11.1M | — | 2026-10-20 |
| 6 | FYC First Trust Small Cap Growth AlphaDEX® Fund | First Trust | 0.68% | $9.2M | $1.3B | 2026-10-20 |
| 7 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.04% | $7.7M | — | 2026-09-30 |
| 8 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $5.7M | — | 2026-05-31 |
| 9 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $5.4M | — | 2026-10-20 |
| 10 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.07% | $5.0M | — | 2026-10-20 |
| 11 | FYX First Trust Small Cap Core AlphaDEX® Fund | First Trust | 0.33% | $4.5M | $1.4B | 2026-10-20 |
| 12 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.35% | $4.3M | $1.2B | 2026-10-20 |
| 13 | VHT Vanguard Health Care ETF | Vanguard | 0.02% | $3.9M | — | 2026-09-30 |
| 14 | XHS State Street® SPDR® S&P® Health Care Services ETF | SPDR (State Street) | 1.39% | $3.1M | $221.4M | 2026-10-20 |
| 15 | FSMD Fidelity Small-Mid Multifactor ETF | Fidelity | 0.11% | $2.7M | $2.5B | 2026-10-20 |
| 16 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.01% | $2.5M | — | 2026-10-20 |
| 17 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.18% | $2.4M | $1.4B | 2026-10-20 |
| 18 | ESML iShares ESG Aware MSCI USA Small-Cap ETF | iShares (BlackRock) | 0.08% | $2.1M | $2.7B | 2026-10-20 |
| 19 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $2.0M | $97.4B | 2026-10-20 |
| 20 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $1.9M | — | 2026-10-20 |
| 21 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.09% | $1.4M | — | 2026-09-30 |
| 22 | VFMO Vanguard U.S. Momentum Factor ETF | Vanguard | 0.07% | $1.3M | — | 2026-10-20 |
| 23 | DUSG Dimensional US Small Cap Growth ETF | Dimensional | 0.06% | $1.2M | — | 2026-10-20 |
| 24 | PSC Principal U.S. Small-Cap ETF | Nport | 0.05% | $1.1M | — | 2026-06-30 |
| 25 | GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | Goldman | 0.08% | $872,200 | $1.0B | 2026-10-20 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $297.98M | $9.08M | $0.25 | $21.83M |
| Q1 '26 | 2026-03-31 | $285.36M | $8.52M | $0.24 | $-3.40M |
| Q4 '25 | 2025-12-31 | $289.32M | $8.64M | $0.25 | $20.96M |
| Q3 '25 | 2025-09-30 | $229.04M | $6.08M | $0.17 | $13.92M |
| Q2 '25 | 2025-06-30 | $219.50M | $7.08M | $0.20 | $34.64M |
| Q1 '25 | 2025-03-31 | $209.84M | $7.78M | $0.22 | $-21.23M |
| Q4 '24 | 2024-12-31 | $188.89M | $5.76M | $0.16 | $20.57M |
| Q3 '24 | 2024-09-30 | $180.69M | $6.21M | $0.20 | $7.69M |
| Q2 '24 | 2024-06-30 | $168.75M | $5.69M | $0.18 | $10.49M |
| Q1 '24 | 2024-03-31 | $156.91M | $4.91M | $0.16 | $545.00K |
| Q4 '23 | 2023-12-31 | $145.95M | $4.35M | $0.14 | $5.18M |
| Q3 '23 | 2023-09-30 | $140.19M | $4.38M | $0.15 | $12.38M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.